M 441
Pill imprint M 441 has been identified as Benazepril hydrochloride 5 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Benazepril 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Benazepril hydrochloride Images
- Imprint:
-
M
441 - Strength:
- 5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
crospovidone
hypromellose
polydextrose
polyethylene glycol
pregelatinized starch
stearic acid
magnesium silicate
titanium dioxide
triacetin
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0441
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66336-0232 | Dispensing Solutions Inc. (repackager) |
| 68258-9062 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More Benazepril Hydrochloride resources
- Benazepril (Wolters Kluwer)
- benazepril (Cerner Multum)
- benazepril (Micromedex) - Includes Dosage Information
- Benazepril Hydrochloride (AHFS DI)
- Benazepril (FDA)
- Benazepril Hydrochloride (Wolters Kluwer)


